177 related articles for article (PubMed ID: 33495406)
1. Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism.
Han J; Zhao Z; Zhang N; Yang Y; Ma L; Feng L; Zhang X; Zuo J; Fan Z; Wang Y; Song Y; Wang G
Aging (Albany NY); 2021 Jan; 13(4):5034-5054. PubMed ID: 33495406
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer.
Jiang T; Tang HM; Lu S; Yan DW; Yang YX; Peng ZH
Med Oncol; 2013 Dec; 30(4):715. PubMed ID: 24078150
[TBL] [Abstract][Full Text] [Related]
3. RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.
Xu W; Xu B; Yao Y; Yu X; Cao H; Zhang J; Liu J; Sheng H
Oncol Rep; 2016 Sep; 36(3):1411-8. PubMed ID: 27430345
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate kinase M1 regulates butyrate metabolism in cancerous colonocytes.
Park B; Kim JY; Riffey OF; Dowker-Key P; Bruckbauer A; McLoughlin J; Bettaieb A; Donohoe DR
Sci Rep; 2022 May; 12(1):8771. PubMed ID: 35610475
[TBL] [Abstract][Full Text] [Related]
5. TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation.
Chen Y; Ma J; Zhang M
Exp Biol Med (Maywood); 2023 Sep; 248(18):1527-1536. PubMed ID: 37837384
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase M2 facilitates colon cancer cell migration via the modulation of STAT3 signalling.
Yang P; Li Z; Fu R; Wu H; Li Z
Cell Signal; 2014 Sep; 26(9):1853-62. PubMed ID: 24686087
[TBL] [Abstract][Full Text] [Related]
7. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells.
Zhou CF; Li XB; Sun H; Zhang B; Han YS; Jiang Y; Zhuang QL; Fang J; Wu GH
IUBMB Life; 2012 Sep; 64(9):775-82. PubMed ID: 22807066
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
Taniguchi K; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Ito Y; Otsuki Y; Uno B; Uchiyama K; Akao Y
Cancer Lett; 2015 Jul; 363(1):17-27. PubMed ID: 25818238
[TBL] [Abstract][Full Text] [Related]
10. p,p'-Dichlorodiphenyltrichloroethane promotes aerobic glycolysis via reactive oxygen species-mediated extracellular signal-regulated kinase/M2 isoform of pyruvate kinase (PKM2) signaling in colorectal cancer cells.
Song L; Dong N; Li Z
Environ Toxicol; 2020 Mar; 35(3):333-345. PubMed ID: 31724279
[TBL] [Abstract][Full Text] [Related]
11. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
Xu J; Li Z; Su Q; Zhao J; Ma J
Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
[TBL] [Abstract][Full Text] [Related]
12. Sam68 promotes aerobic glycolysis in colorectal cancer by regulating PKM2 alternative splicing.
Zhao J; Li J; Hassan W; Xu D; Wang X; Huang Z
Ann Transl Med; 2020 Apr; 8(7):459. PubMed ID: 32395503
[TBL] [Abstract][Full Text] [Related]
13. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis.
Yu S; Zang W; Qiu Y; Liao L; Zheng X
Oncogene; 2022 Jan; 41(1):46-56. PubMed ID: 34671086
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1.
Deng X; Fu X; Teng H; Fang L; Liang B; Zeng R; Chen L; Zou Y
J Transl Med; 2021 Aug; 19(1):332. PubMed ID: 34353343
[TBL] [Abstract][Full Text] [Related]
16. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1.
Liu J; Shao Y; He Y; Ning K; Cui X; Liu F; Wang Z; Li F
Cancer Sci; 2019 Jan; 110(1):135-146. PubMed ID: 30407715
[TBL] [Abstract][Full Text] [Related]
17. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase M2 accelerates pro-inflammatory cytokine secretion and cell proliferation induced by lipopolysaccharide in colorectal cancer.
Yang P; Li Z; Li H; Lu Y; Wu H; Li Z
Cell Signal; 2015 Jul; 27(7):1525-32. PubMed ID: 25778902
[TBL] [Abstract][Full Text] [Related]
19. Loss of PKM2 in Lgr5
Kim Y; Lee YS; Kang SW; Kim S; Kim TY; Lee SH; Hwang SW; Kim J; Kim EN; Ju JS; Park YY; Kweon MN
Sci Rep; 2019 Apr; 9(1):6212. PubMed ID: 30996297
[TBL] [Abstract][Full Text] [Related]
20. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
